State Street’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,466
Closed -$14.6K 4253
2026
Q1
$14.6K Hold
4,466
﹤0.01% 4233
2025
Q4
$31.5K Hold
4,466
﹤0.01% 4207
2025
Q3
$50.7K Hold
4,466
﹤0.01% 4155
2025
Q2
$103K Sell
4,466
-20,574
-82% -$574K ﹤0.01% 3969
2025
Q1
$1.09M Sell
25,040
-771
-3% -$49.3K ﹤0.01% 3409
2024
Q4
$1.73M Buy
25,811
+9,263
+56% +$615K ﹤0.01% 3366
2024
Q3
$640K Buy
16,548
+602
+4% +$41.7K ﹤0.01% 3549
2024
Q2
$2.23M Buy
15,946
+14,725
+1,206% +$2.01M ﹤0.01% 3285
2024
Q1
$259K Hold
1,221
﹤0.01% 3816
2023
Q4
$310K Buy
1,221
+429
+54% +$118K ﹤0.01% 3772
2023
Q3
$283K Buy
792
+141
+22% +$21.4K ﹤0.01% 3836
2023
Q2
$29.5K Sell
651
-3,192
-83% -$245K ﹤0.01% 4533
2023
Q1
$281K Buy
3,843
+23
+0.6% +$2.02K ﹤0.01% 3949
2022
Q4
$315K Sell
3,820
-134
-3% -$18K ﹤0.01% 3932
2022
Q3
$573K Sell
3,954
-2
-0.1% -$365 ﹤0.01% 3730
2022
Q2
$611K Buy
3,956
+3,305
+508% +$1.51M ﹤0.01% 3761
2022
Q1
$430K Buy
651
+47
+8% +$25K ﹤0.01% 4114
2021
Q4
$352K Hold
604
﹤0.01% 4131
2021
Q3
$325K Buy
604
+194
+47% +$94.8K ﹤0.01% 4152
2021
Q2
$163K Sell
410
-1,942
-83% -$633K ﹤0.01% 4262
2021
Q1
$666K Buy
2,352
+4
+0.2% +$1.18K ﹤0.01% 3698
2020
Q4
$554K Sell
2,348
-59
-2% -$14.9K ﹤0.01% 3632
2020
Q3
$689K Buy
2,407
+476
+25% +$150K ﹤0.01% 3521
2020
Q2
$651K Buy
1,931
+396
+26% +$119K ﹤0.01% 3504
2020
Q1
$368K Buy
1,535
+767
+100% +$228K ﹤0.01% 3500
2019
Q4
$308K Buy
768
+370
+93% +$163K ﹤0.01% 3581
2019
Q3
$175K Sell
398
-8
-2% -$3.06K ﹤0.01% 3621
2019
Q2
$106K Buy
+406
New +$198K ﹤0.01% 3668

Other funds holding LNAI

State Street's LNAI Position: Q2 2026 in Review

State Street sold out of Lunai Bioworks (LNAI) in Q2 2026, closing a stake of 4,466 shares — an estimated $14.6K sold.

State Street first reported a position in LNAI in Q2 2019 and held it in 28 quarters. The position peaked at $2.23M in Q2 2024. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • State Street reported no remaining Lunai Bioworks position as of Q2 2026 after selling out during the quarter.
  • State Street sold 4,466 Lunai Bioworks shares in Q2 2026, an estimated $14.6K.
  • State Street first reported a position in Lunai Bioworks in Q2 2019 and held it in 28 quarters.
  • State Street's Lunai Bioworks position peaked at $2.23M in Q2 2024.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.